The human POLH gene is not mutated, and is expressed in a cohort of patients with basal or squamous cell carcinoma of the skin

International Journal of Molecular Medicine

Volumn 19, Issue 4, 2007, Pages 589-596

  Flanagan, Annabelle M ^a,c   Rafferty, Gerard ^a   O'Neill, Anne ^b   Rynne, Leonie ^b   Kelly, Jack ^b   McCann, Jack ^b   Carty, Michael P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

DNA polymerase ; Genotyping; POLH; Skin cancer

Indexed keywords

DNA DIRECTED DNA POLYMERASE; DNA DIRECTED DNA POLYMERASE ETA; MESSENGER RNA;

AGED; ALTERNATIVE RNA SPLICING; ARTICLE; COHORT ANALYSIS; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DNA-DIRECTED DNA POLYMERASE; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; POLYMORPHISM, GENETIC; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS;

EID: 34247897059     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.4.589     Document Type: Article

References (34)

1. Schork N, Fallin D and Lanchbury S: Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet 58: 250-264, 2000.
2. Peto J: Cancer epidemiology in the last century and the next decade. Nature 411: 390-395, 2001. (Pubitemid 32467050)
3. Cleaver J: Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum. J Dermatol Sci 23: 1-11, 2000.
4. Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, Yuasa M, Araki M, Iwai S, Takio K and Hanaoka F: The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η. Nature 399: 700-704, 1999.
5. Johnson RE, Kondratick CM, Prakash S and Prakash L: hPOLH mutations in the variant form of xeroderma pigmentosum. Science 285: 263-265, 1999. (Pubitemid 29330001)
6. Yuasa M, Masutani C, Eki T and Hanaoka F: Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene. Oncogene 19: 4721-4728, 2000.
7. Masutani C, Kusumoto R, Iwai S and Hanaoka F: Mechanisms of translesion synthesis by human DNA polymerase η. EMBO J 19: 3100-3109, 1999.
8. Yao J, Dixon K and Carty MP: A single (6-4) photoproduct inhibits plasmid DNA replication in xeroderma pigmentosum variant cell extracts. Environ Mol Mutagen 38: 19-29, 2001.
9. Woodgate R: A plethora of lesion-replicating DNA polymerases. Genes Dev 13: 2191-2195, 1999.
10. Johnson RE, Washington MT, Haracska L, Prakash S and Prakash L: Eukaryotic polymerases ι and ς act sequentially to bypass DNA lesions. Nature 406: 1015-1019, 2000.
11. Gibbs PEM, Wang X-D, Li Z, McManus TP, McGregor G, Lawrence CW and Maher VM: The function of the human homolog of Saccharomyces cerevisiae REV1 is required for mutagenesis induced by UV light. Proc Natl Acad Sci USA 97: 4186-4191, 2000.
12. Lin Q, Clark AB, McCulloch AB, Yuan T, Bronson RT, Kunkel TA and Kucherlapati R: Increased susceptibility to UV-induced skin carcinogenesis in polymerase η-deficient mice. Cancer Res 66: 87-94, 2006. (Pubitemid 43166013)
13. Broughton BC, Cordonnier A, Kleijer WJ, Jaspers NG, Fawcett H, Raams A, Garritsen VH, Stary A, Avril MF, Boudsocq F, Masutani C, Hanaoka F, Fuchs RP, Sarasin A and Lehmann A: Molecular analysis of mutations in DNA polymerase η in xeroderma pigmentosum variant patients. Proc Natl Acad Sci USA 99: 815-820, 2002.
14. Thakur M, Wernick M, Collins C, Limoli C, Crowley E and Cleaver JE: DNA polymerase η undergoes alternative splicing, protects against UV sensitivity and apoptosis, and suppresses Mre11-dependent recombination. Genes Chromosomes Cancer 32: 222-235, 2001. (Pubitemid 32953976)
15. Yamanda A, Masutani C, Iwai S and Hanaoka F: Complementation of defective translesion synthesis and UV light sensitivity in xeroderma pigmentosum variant cells by mouse and human DNA polymerase η. Nucleic Acids Res 28: 2473-2480, 2000.
16. McCulloch SD, Kokoska RJ, Masutani C, Iwai S, Hanaoka F and Kunkel TA: Preferential cis-syn thymine dimer bypass by DNA polymerase η occurs with biased fidelity. Nature 428: 97-100, 2004. (Pubitemid 38332365)
17. Scanlon K, Kashani-Sabet M and Miyachi H: Differential gene expression in human cancer cells resistant to cisplatin. Cancer Invest 7: 581-587, 1989. (Pubitemid 20161623)
18. Srivastava D, Husain I, Arteaga C and Wilson S: DNA pol β expression differences in selected human tumours and cell lines. Carcinogenesis 20: 1049-1054, 1999. (Pubitemid 29263750)
19. Canitrot Y, Cazaux C, Frechet M, Bouayadi K, Lesca C, Salles B and Hoffmann J: Overexpression of DNA polymerase β in cells results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc Natl Acad Sci USA 95: 12586-12590, 1998.
20. Servant L, Cazaux C, Bieth A, Iwai S, Hanaoka F and Hoffmann J: A role for DNA polymerase β in mutagenic UV lesion bypass. J Biol Chem 277: 50046-50053, 2002.
21. Albertella MR, Lau A and O'Connor MJ: The overexpression of specialised DNA polymerases in cancer. DNA Repair 4: 583-593, 2005.
22. O-Wang J, Kawamura K, Tada Y, Ohmori H, Kimura H, Sakiyama S and Tagawa M: DNA polymerase κ, implicated in spontaneous and DNA damage-induced mutagenesis, is overexpressed in lung cancer. Cancer Res 61: 5366-5369, 2001.
23. Wang M, Devereux TR, Vikis HG, et al: Pol ι is a candidate for the mouse pulmonary adenoma resistance 2 locus, a major modifier of chemically induced lung neoplasia. Cancer Res 64: 1924-1931, 2004.
24. Yang J, Chen Z, Liu Y, Hickey RJ and Malkas LH: Altered DNA polymerase ι expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis. Cancer Res 64: 5597-5607, 2004.
25. Carty MP, Glynn M, Maher M, Smith T, Yao J, Dixon K, McCann J, Rynn L and Flanagan A: The RAD30 cancer susceptibility gene. Biochem Soc Trans 31: 252-256, 2003.
26. Yuasa M, Masutani C, Eki T and Hanaoka F: Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene. Oncogene 19: 4721-4728, 2000.
27. Vaughan P and McCarthy TV: Glycosylase mediated polymorphism detection (GMPD) - a novel process for genetic analysis. Genet Anal 14: 169-175, 1999.
28. Vaughan P (ed): Use of uracil-DNA glycosylase in scanning for unknown DNA mutations and polymorphisms: Glycosylase-mediated polymorphism detection (GMPD-scan). DNA Repair Protocols. In: Methods in Molecular Biology. Vol. 152. Humana Press, NJ, pp179-186, 2000.
29. Cruet-Hennequart S, Coyne S, Glynn MT, Oakley GG and Carty MP: UV-induced RPA phosphorylation is increased in the absence of DNA polymerase η and requires DNA-PK. DNA Repair 5: 491-504, 2006.
30. Glick E, White LM, Elliott NA, Berg D, Kiviat NB and Loeb LA: Mutations in DNA polymerase η are not detected in squamous cell carcinoma of the skin. Int J Cancer 119: 2225-2227, 2006.
31. Zmudzka B, Fornace A, Collins J and Wilson S: Characterization of DNA pol beta mRNA: cell cycle and growth response in cultured human cells. Nucleic Acids Res 16: 9589-9596, 1988.
32. Bergolio V, Canitrot Y, Hogarth L, Minto L, Howell SB, Cazaux C and Hoffmann J-S: Enhanced expression and activity of DNA polymerase β in human ovarian tumor cells: impact on sensitivity towards antitumour agents. Oncogene 20: 6181-6187, 2001.
33. Bergoglio V, Frechet M, Phillipe M, Bieth A, Mercier P, Morello D, Lacroix-Tricki M, Delsof G, Hoffmann J-S and Cazaux C: Evidence of finely tuned expression of DNA polymerase β in vivo using transgenic mice. FEBS Lett 566: 147-150, 2004.
34. Kawamura K, Bahar R, Seimiya M, et al: DNA polymerase θ is preferentially expressed in lymphoid tissues and upregulated in human cancers. Int J Cancer 109: 9-16, 2003.